Skip to main content
Supporting the dream

Two pillars

Our platform rests on two foundational technologies that together enable unprecedented control over biological systems.

PILLAR 01

World's most advanced genome synthesis platform

World's largest synthetic organisms (base pairs)

5K
phiX174
2003
530K
JCVI-syn3.0
2016
1.1M
JCVI-syn1.0
2010
4.0M
6x cheaper
3x faster
Syn61
2019

Only Constructive Bio can write genomes from scratch and recode entire organisms

PILLAR 02

World's most advanced translation machinery engineering

Chemical space for protein building blocks

20 canonical
amino acids

+
+
+
+

3 additional slots
hundreds of chemistries

...

Only Constructive Bio can incorporate multiple ncAAs into a single molecule

Pillar 1

Synthetic genomics

We design and build entire genomes from scratch, creating organisms with fundamentally new properties.

Our Syn61 strain represents the cutting edge of synthetic biology - a completely synthetic E. coli genome with a compressed genetic code.

1

De-novo genome design

Complete freedom to design genomes with any desired properties

2

Codon compression

Freeing up codons for new functions by systematic genome-wide recoding

3

Syn61 chassis

World's first organism with a fully synthetic, compressed genome

4

Genome-scale engineering

Making thousands of precise changes across entire genomes

Synthetic genomics - Genome-scale design and construction
Engineered translation - ncAA incorporation and programmable polymers
Pillar 2

Engineered translation

We expand the genetic code to incorporate non-canonical amino acids at precise positions.

By engineering the translation machinery, we can produce proteins and peptides with chemistries that nature never evolved.

1

Genetic code expansion

Adding new amino acids to the genetic code

2

Orthogonal systems

Dedicated tRNA/synthetase pairs for each ncAA

3

Site-specific incorporation

Precise positioning of ncAAs in any sequence

4

Multi-ncAA proteins

Multiple different ncAAs in a single molecule

Built on strong IP

Our technology is protected by an extensive patent portfolio covering synthetic genomics and genetic code expansion.

Foundational patents

Core IP from MRC Laboratory of Molecular Biology

Exclusive licenses

Exclusive rights to key enabling technologies

Ongoing innovation

Continuous expansion of our IP portfolio

View publications